RHHBF (RHHBF) Stock Price & Analysis
RHHBF (RHHBF) rose 1.13% to USD 430 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
RHHBF last closed at USD 425.19; the session ranged USD 430–430 on volume of 32 shares. Market capitalization is $342.61B, with a 52-week range of USD 296.1–514.08 (OQX). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 430 |
|---|---|
| Change | ▲ 1.13% (up) |
| Previous Close | USD 425.19 |
| Open | USD 430 |
| Day Range | USD 430 – 430 |
| 52-Week Range | USD 296.1 – 514.08 |
| Volume | 32 shares |
| Market Cap | $342.61B |
| Exchange | OQX |
Technical Analysis (RHHBF)
Nexqual's technical model rates RHHBF "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.5 (neutral) |
| vs SMA50 | Above (USD 419.64) |
| MACD | 2.97 (positive) |
Analyst Ratings (RHHBF)
Wall Street analysts rate RHHBF "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (RHHBF)
| Revenue Estimate | $15.42B |
|---|
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (RHHBF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (RHHBF)
Nexqual rates RHHBF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Mixed — Revenue +1.7% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (RHHBF)
| Insider Ownership | +72.31% |
|---|---|
| Institutional Ownership | +10.92% |
| Shares Outstanding | 106.69M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (RHHBF)
RHHBF is led by Thomas Schinecker (age 50), Group Chief Executive Officer, per Nexqual as of July 25, 2026 at 02:21 UTC.
| Group Chief Executive Officer | Thomas Schinecker (age 50) |
|---|---|
| Executive Chairman | Severin Schwan (age 58) |
| Chief Financial Officer | Alan Hippe (age 58) |
Major Backers & Investors (RHHBF)
Notable institutional backers of RHHBF include Fidelity, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.86% |
| BlackRock | 0.32% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RHHVF | Roche Holding Ltd | USD 437 | ▲ 7.38% |
| NVSEF | Novartis AG | USD 154.47 | ▲ 0.95% |
| NONOF | Novo-Nordisk A/S | USD 49.25 | ▲ 1.57% |
| LRLCF | L'Oreal Co. | USD 415 | ▼ 3.62% |
| NSRGF | Nestle S.A. | USD 99.5 | ▼ 4.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.